Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-13

FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approves a supplemental application for TOBI PODHALER (tobramycin) from Viatris Specialty LLC. The approval updates the product’s labeling/indications as de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBI Podhaler (tobramycin inhalation powder)

Snippet

SUPPL AP for TOBI PODHALER (TOBRAMYCIN)